clemastine (Tavist)

Introduction

Tradename: Tavist. (clemastine fumarate)

Dosage

1.34 mg PO BID

Tabs: 1.34 & 2.68 mg.

Syrup: 0.67 mg/5 mL.

Adverse effects

• sedation; less sedating than diphenhydramine, but more sedating than chlorpheniramine

• drug adverse effects of H1 receptor antagonists
• drug adverse effects of psychotropic agents
• drug adverse effects of sedatives

More general terms

• H1 receptor antagonist (antihistamine)
• sedative/hypnotic (tranquilizer)

Component of

• clemastine/phenylpropanolamine
• clemastine/diphenhydramine/pseudoephedrine
• chlorpheniramine/clemastine/pseudoephedrine
• acetaminophen/clemastine/fumarate/pseudoephedrine
• acetaminophen/clemastine/pseudoephedrine

Database

• PubChem: http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=26987
• PubChem: http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=2781
• PubChem: http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=26986
• PubChem: http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=5281069